ALVO
Price
$4.12Alerts
Change
-$0.17 (-3.96%)
Updated
Nov 20 closing price
Capitalization
1.73B
110 days until earnings call
Intraday BUY SELL Signals
GLCR
Price
$22.56Alerts
Change
-$0.14 (-0.62%)
Updated
Nov 20 closing price
Net Assets
1.4M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALVO vs GLCR

ALVO vs GLCR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALVO vs. GLCR commentary
Nov 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and GLCR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ALVO with price predictions
Nov 20, 2026

ALVO in downward trend: 10-day moving average broke below 50-day moving average on October 22, 2026

The 10-day moving average for ALVO crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALVO as a result. In 74 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The Moving Average Convergence Divergence Histogram (MACD) for ALVO turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 34 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.

ALVO moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for ALVO entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALVO's RSI Oscillator exited the oversold zone, 27 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +4.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALVO advanced for three days, in 199 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

ALVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-9.057) is normal, around the industry mean (6.379). P/E Ratio (-7.839) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.061) among similar stocks. P/S Ratio (3.071) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. ALVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for GLCR with price predictions
Nov 20, 2026

GLCR in -1.76% downward trend, declining for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where GLCR declined for three days, in 47 of 62 cases, the price declined further within the following month. The odds of a continued downward trend are 76%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GLCR as a result. In 13 of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.

The Moving Average Convergence Divergence Histogram (MACD) for GLCR turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 12 similar instances when the indicator turned negative. In 9 of the 12 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.

The Aroon Indicator for GLCR entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where GLCR advanced for three days, in 30 of 44 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

GLCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

FUNDAMENTALS RATINGS
ALVO: Fundamental Ratings
ALVO
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVOGLCR
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
68%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
68%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 10 days ago
74%
Bullish Trend 10 days ago
68%
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
55%
Aroon
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
72%
COMPARISON
Comparison
Nov 21, 2026
Stock price -- (ALVO: $4.29)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green while .

  • ALVO’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 4 TA indicator(s) are bullish.

  • ALVO’s TA Score: 4 bullish, 6 bearish.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а -8.14% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -7.46%. For the same industry, the average monthly price growth was -10.68%, and the average quarterly price growth was -13.10%.

Reported Earning Dates

ALVO is expected to report earnings on Mar 10, 2027.

Industries' Descriptions

@Pharmaceuticals: Generic (-7.46% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-3.96%
EBS - ALVO
30%
Poorly correlated
-1.94%
CRON - ALVO
24%
Poorly correlated
-1.30%
SIGA - ALVO
23%
Poorly correlated
-9.43%
XERS - ALVO
23%
Poorly correlated
+2.11%
PAHC - ALVO
22%
Poorly correlated
-2.32%
More

GLCR and

Correlation & Price change

A.I.dvisor tells us that GLCR and ALVO have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GLCR and ALVO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLCR
1D Price
Change %
GLCR100%
-0.66%
ALVO - GLCR
2%
Poorly correlated
-3.96%
OCS - GLCR
0%
Poorly correlated
-5.11%
JBTM - GLCR
-2%
Poorly correlated
-1.55%
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WBI24.91-0.08
-0.32%
WaterBridge Infrastructure LLC
DSX2.21-0.04
-1.78%
Diana Shipping
UBER63.47-2.13
-3.25%
Uber Technologies
LVO2.61-0.10
-3.69%
LiveOne Inc
MP33.95-2.71
-7.39%
MP Materials Corp